Drugs / Autologous serum
Autologous serum
Trials 10 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT07014059 | Jun 2025 → Jun 2026 overdue | Sjogren syndrome, Stevens-Johnson syndrome, corneal ulcer, graft versus host disease +2 | GIANCARLO FATOBENE | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT00779987 | Oct → Dec 2008 | dry eye syndrome | University of Chile | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT05598242 | Feb → Sep 2019 | Sjogren syndrome, dry eye syndrome | Hospital Nacional Profesor Alejandro Posadas | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT04492774 | Jul 2020 → Dec 2022 | lumbar spinal stenosis | Sutherland Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT03608761 | Feb → Oct 2017 | Sjogren syndrome, dry eye syndrome | Hospital Nacional Profesor Alejandro Posadas | Completed | No outcome recorded |
| Phase 4 | NCT02752763 | Oct 2015 → Mar 2016 | dry eye syndrome | Niğde State Hospital | Completed | No outcome recorded |
| Phase not applicable4 trials | ||||||
| — | NCT02291731 | Sep 2014 → Aug 2015 | corneal disorder | E-DA Hospital | Completed | No outcome recorded |
| — | NCT02147509 | Mar 2013 → Apr 2014 | Sjogren syndrome | Jinyang Li | Completed | No outcome recorded |
| — | NCT00238862 | Oct 2005 → Sep 2006 | corneal disorder | King Khaled Eye Specialist Hospital | Completed | No outcome recorded |
| — | NCT00442273 | — | dry eye syndrome | Chonnam National University Hospital | Completed | No outcome recorded |
Also used as a comparator or background therapy in 6 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05331859 Comparator | May → Aug 2022 | corneal disorder | Benha University | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT07551843 Comparator | Oct 2023 → Dec 2024 | dry eye syndrome | G.Gennimatas General Hospital | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT04683796 Comparator | Feb 2021 → Feb 2023 | dry eye syndrome | Mahidol University | Completed | No outcome recorded |
| Phase 3 | NCT03436576 Comparator | Sep → Oct 2018 | Sjogren syndrome, dry eye syndrome | Pontificia Universidad Catolica de Chile | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03666884 Comparator | Oct 2015 → Mar 2016 | dry eye syndrome | Seref istek | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05944757 Comparator | Sep 2021 → Sep 2023 | — | Anita Syla Lokaj | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 17 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous serum | “AIM: To evaluate the efficacy of autologous serum application for the treatment of dry eye in Sjögren's syndrome.” PMID 10434857 ↗ Apr 199915“autologous serum GOLDIC administered by epidural injection (into the vertebral canal)” PMID 35899459 ↗ Jul 2022 “autologous serum eye drops (ASED)” NCT05598242 ↗ “AS: Autologous Serum” NCT02147509 ↗ |
| Known as | ASED | “Autologous serum eye drops (ASED) are an established therapy for ocular surface diseases;” NCT07014059 ↗1“autologous serum eye drops (ASED)” NCT05598242 ↗ |
| Known as | Goldic serum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04492774 ↗ |
| Route | Topical | “Autologous serum eyedrops” NCT00442273 ↗ |